1. Home
  2. BOLT vs FBGL Comparison

BOLT vs FBGL Comparison

Compare BOLT & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • FBGL
  • Stock Information
  • Founded
  • BOLT 2015
  • FBGL 1996
  • Country
  • BOLT United States
  • FBGL Singapore
  • Employees
  • BOLT N/A
  • FBGL N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • FBGL Miscellaneous manufacturing industries
  • Sector
  • BOLT Health Care
  • FBGL Consumer Discretionary
  • Exchange
  • BOLT Nasdaq
  • FBGL Nasdaq
  • Market Cap
  • BOLT 9.4M
  • FBGL 8.4M
  • IPO Year
  • BOLT 2021
  • FBGL 2025
  • Fundamental
  • Price
  • BOLT $5.19
  • FBGL $0.55
  • Analyst Decision
  • BOLT Buy
  • FBGL
  • Analyst Count
  • BOLT 3
  • FBGL 0
  • Target Price
  • BOLT $47.50
  • FBGL N/A
  • AVG Volume (30 Days)
  • BOLT 14.4K
  • FBGL 497.5K
  • Earning Date
  • BOLT 08-14-2025
  • FBGL 01-01-0001
  • Dividend Yield
  • BOLT N/A
  • FBGL N/A
  • EPS Growth
  • BOLT N/A
  • FBGL N/A
  • EPS
  • BOLT N/A
  • FBGL N/A
  • Revenue
  • BOLT $4,167,000.00
  • FBGL $10,146,582.00
  • Revenue This Year
  • BOLT N/A
  • FBGL N/A
  • Revenue Next Year
  • BOLT N/A
  • FBGL N/A
  • P/E Ratio
  • BOLT N/A
  • FBGL N/A
  • Revenue Growth
  • BOLT N/A
  • FBGL N/A
  • 52 Week Low
  • BOLT $4.59
  • FBGL $0.44
  • 52 Week High
  • BOLT $14.36
  • FBGL $5.45
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 46.64
  • FBGL N/A
  • Support Level
  • BOLT $4.81
  • FBGL N/A
  • Resistance Level
  • BOLT $5.28
  • FBGL N/A
  • Average True Range (ATR)
  • BOLT 0.26
  • FBGL 0.00
  • MACD
  • BOLT 0.01
  • FBGL 0.00
  • Stochastic Oscillator
  • BOLT 70.26
  • FBGL 0.00

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.

Share on Social Networks: